NCT00052897View on ClinicalTrials.gov

SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

July 31, 2005

Conditions
Anal Cancer
Interventions
BIOLOGICAL

HspE7

Trial Locations (1)

94143

UCSF Comprehensive Cancer Center, San Francisco

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00052897 - SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia | Biotech Hunter | Biotech Hunter